tradingkey.logo
tradingkey.logo
Pesquisar

Lifecore Biomedical Inc

LFCR
Adicionar à lista de desejos
5.090USD
-0.180-3.42%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
190.76MValor de mercado
PerdaP/L TTM

Mais detalhes de Lifecore Biomedical Inc Empresa

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Informações de Lifecore Biomedical Inc

Código da empresaLFCR
Nome da EmpresaLifecore Biomedical Inc
Data de listagemFeb 15, 1996
CEOJosephs (Paul)
Número de funcionários406
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 15
Endereço3515 Lyman Boulevard
CidadeCHASKA
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal55318
Telefone19523684300
Sitehttps://www.lifecore.com/
Código da empresaLFCR
Data de listagemFeb 15, 1996
CEOJosephs (Paul)

Executivos da empresa Lifecore Biomedical Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
115.57K
+22.42%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
50.46K
+51.34%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
25.91K
--
Mr. Christopher S. Kiper
Mr. Christopher S. Kiper
Independent Director
Independent Director
25.91K
--
Katrina L. Houde
Katrina L. Houde
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Paul H. Johnson
Mr. Paul H. Johnson
Independent Director
Independent Director
--
--
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Independent Director
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
292.92K
-13.80%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
133.16K
+57.96%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
--
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
115.57K
+22.42%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
50.46K
+51.34%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
25.91K
--

Perguntas frequentes

Quem são os cinco principais acionistas de Lifecore Biomedical Inc?

Os cinco principais acionistas de Lifecore Biomedical Inc são: Mr. Paul Josephs

Quantas instituições possuem ações da Lifecore Biomedical Inc (LFCR)?

Em 2026Q1, 225 instituições possuíam ações da Lifecore Biomedical Inc, com valor de mercado aproximado de 30.56M, representando 81.48% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em 1031462.00.

Qual é a maior fonte de receita da Lifecore Biomedical Inc?

Em 2026Q1, o segmento de negócios Contract development and manufacturing organization ("CDMO") gerou a maior receita para Lifecore Biomedical Inc, totalizando 17.81M e representando 64.53% da receita total.